3D Tension-Cultured Artificial Tendons With Layered Strength
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for producing tendon/ligament-like artificial tissues are limited by the fragility and size of the resulting tissues, lack of a layered structure, and insufficient strength, which hinders their clinical application and regeneration of tendon/ligament injuries.
Innovation Solution
A novel culture method involving staged introduction of tendon cells and gel, combined with tension loading, using a three-dimensional mechanosignal cell culture system, to produce artificial tendons/ligaments with a layered structure and increased width and thickness, utilizing mesenchymal stem cells derived from human iPS cells.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of manufacture
If cells and gel are added at the start of culture and culture is continued, then the culture process is simple, but the resulting tendon tissue is fragile and limited in size
Solution Approach 1:
The culture process is divided into multiple stages: initial cell embedding, intermediate gel addition, and final maturation phase. This segmentation allows the tendon tissue to develop progressively stronger structural layers, with each phase contributing to overall tissue strength while maintaining manageable cultural conditions throughout.
2Ease of manufacture
If cells and gel are added at the start of culture, then the initial setup is straightforward, but the tendon tissue lacks layered structure
Solution Approach 1:
The method performs preliminary actions by first establishing a cellular foundation, then adding gel layers at specific intermediate stages to create distinct structural layers. This staged approach preliminarily establishes the framework for layered organization, allowing each layer to form with proper cellular and extracellular matrix arrangement before the next layer is added.
3Quantity of substance
If a large amount of cells are added at once, then cell population is sufficient, but cell necrosis occurs and tendons become fragile
Solution Approach 1:
The cell population is segmented and added in controlled portions at different culture stages rather than all at once. This segmentation prevents overcrowding and necrosis while ensuring sufficient cell numbers accumulate progressively, maintaining tendon integrity throughout the culture process.
4Device complexity
If conventional culture methods are used, then the process is simple, but the tendon size and width are limited
Solution Approach 1:
The culture method transitions from two-dimensional or simple three-dimensional culture to a complex three-dimensional system with multiple added dimensions: temporal dimension (staged additions over time), spatial dimension (layered structure formation), and compositional dimension (multiple cell and gel types). This dimensional expansion enables production of larger tendon tissues while maintaining biological functionality.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The method results in artificial tendons/ligaments that are twice as wide and thick, with nearly three times the tension strength, resembling biological tissues, enabling minimally invasive treatments for tendon/ligament injuries and expanding clinical applications.
Implementation Method 1
embedding cells in a gel having strength to withstand tension load
Implementation Method 2
culturing the cells while applying a tension load to the gel
Data Source
AI summary
The purpose of the present invention is to provide tendon/ligament-like artificial tissues with sufficient strength. The present invention provides tendon/ligament-like artificial tissues having sufficient strength, by embedding mesodermal stem cells, mesenchymal stem cells, or such in a gel having strength to withstand tension loading, and culturing the cells while applying tension loading to the gel and while adding cells and gel. Human iPS cells, tissue stem cells, or such can be used for mesodermal and mesenchymal stem cells, and such.